Pathophysiology and management of Staphylococcus aureus in nasal polyp disease

References

• Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6:86.
   PubMed Web of Science ®Google Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–56.e4. doi: 10.1016/j.jaci.2015.12.1324
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang N, Bo M, et al. Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344–1353.
   PubMed Web of Science ®Google Scholar
• Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607–614. doi: 10.1067/mai.2001.112374
   PubMed Web of Science ®Google Scholar
• Grumann D, Nübel U, Bröker BM. Staphylococcus aureus toxins – Their functions and genetics. Infect Genet Evol. 2014;21:583–592. doi: 10.1016/j.meegid.2013.03.013
   PubMed Web of Science ®Google Scholar
• Schmidt F, Völker U, Sundaramoorthy N, et al. Characterization of human and Staphylococcus aureus proteins in respiratory mucosa by in vivo- and immunoproteomics. Journal Proteomics. 2017;155:31–39.
   PubMed Web of Science ®Google Scholar
• Rha MS, Kim SW, Chang DY, et al. Superantigen-related T(H)2 CD4(+) T cells in nonasthmatic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145:1378–88.e10. doi: 10.1016/j.jaci.2019.12.915
   PubMed Web of Science ®Google Scholar
• Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol. 2010;126:962-8, 8 e1–6. doi: 10.1016/j.jaci.2010.07.007
   Web of Science ®Google Scholar
• Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol. 2008;121:110–115. doi: 10.1016/j.jaci.2007.08.059
   PubMed Web of Science ®Google Scholar
• Bernstein JM, Allen C, Rich G, et al. Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposis. Laryngoscope. 2011;121(3):647–655. doi: 10.1002/lary.21400
   PubMed Web of Science ®Google Scholar
• Tomassen P, Jarvis D, Newson R, et al. Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN study. Allergy. 2013;68:1289–1297. doi: 10.1111/all.12230
   PubMed Web of Science ®Google Scholar
• Breuer K, Wittmann M, Bösche B, et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy. 2000;55(6):551–555. doi: 10.1034/j.1398-9995.2000.00432.x
   PubMed Web of Science ®Google Scholar
• Caruso C, Colantuono S, Ciasca G, et al. Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity. Allergy. 2022;78(1):131–140. doi: 10.1111/all.15466
   PubMed Web of Science ®Google Scholar
• Wei B, Liu F, Zhang J, et al. Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population. Rhinology. 2018;56(3):216–226. doi: 10.4193/Rhin17.240
   PubMed Web of Science ®Google Scholar
• Shamji MH, Thomsen I, Layhadi JA, et al. Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses. J Allergy Clin Immunol. 2019;143(6):2086–94.e2. doi: 10.1016/j.jaci.2019.02.001
   PubMed Web of Science ®Google Scholar
• Calus L, Derycke L, Dullaers M, et al. IL-21 is increased in nasal polyposis and after stimulation with staphylococcus aureus enterotoxin B. Int Arch Allergy Immunol. 2017;174(3–4):161–169. doi: 10.1159/000481435
   PubMed Web of Science ®Google Scholar
• Chen JB, James LK, Davies AM, et al. Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2017;139(4):1195–204.e11. doi: 10.1016/j.jaci.2016.06.066
   PubMed Web of Science ®Google Scholar
• Martens K, Seys SF, Alpizar YA, et al. Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity. Clin Exp Allergy. 2021;51(1):87–98. doi: 10.1111/cea.13760
   PubMed Web of Science ®Google Scholar
• Liu C, Chi K, Yang M, et al. Staphylococcal enterotoxin a induces intestinal barrier dysfunction and activates NLRP3 inflammasome via NF-κB/MAPK signaling pathways in mice. Toxins (Basel). 2022;14(1):14. doi: 10.3390/toxins14010029
   Web of Science ®Google Scholar
• Jin J, Yoon YH, Kwak SY, et al. Staphylococcal enterotoxin B induced expression of IL-17A in nasal epithelial cells and its association with pathogenesis of nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271:525–534. doi: 10.1007/s00405-013-2589-7
   PubMed Web of Science ®Google Scholar
• Noyama Y, Okano M, Fujiwara T, et al. IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression. Allergol Int. 2017;66(1):42–51. doi: 10.1016/j.alit.2016.04.017
   PubMed Web of Science ®Google Scholar
• Haruna T, Kariya S, Fujiwara T, et al. Association between impaired IL-10 production following exposure to Staphylococcus aureus enterotoxin B and disease severity in eosinophilic chronic rhinosinusitis. Allergol Int. 2018;67(3):392–398. doi: 10.1016/j.alit.2018.02.001
   PubMed Web of Science ®Google Scholar
• Yoon YH, Yeon SH, Choi MR, et al. Altered mitochondrial functions and morphologies in epithelial cells are associated with pathogenesis of chronic rhinosinusitis with nasal polyps. Allergy Asthma Immunol Res. 2020;12(4):653–668. doi: 10.4168/aair.2020.12.4.653
   PubMed Web of Science ®Google Scholar
• Kim YM, Jin J, Choi JA, et al. Staphylococcus aureus enterotoxin B-induced endoplasmic reticulum stress response is associated with chronic rhinosinusitis with nasal polyposis. Clin Biochem. 2014;47(1–2):96–103. doi: 10.1016/j.clinbiochem.2013.10.030
   PubMed Web of Science ®Google Scholar
• Rouyar A, Classe M, Gorski R, et al. Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model. Allergy. 2019;74(3):549–559. doi: 10.1111/all.13559
   PubMed Web of Science ®Google Scholar
• Popowicz GM, Dubin G, Stec-Niemczyk J, et al. Functional and structural characterization of Spl proteases from Staphylococcus aureus. J Mol Biol. 2006;358(1):270–279. doi: 10.1016/j.jmb.2006.01.098
   PubMed Web of Science ®Google Scholar
• Nordengrün M, Abdurrahman G, Treffon J, et al. Allergic reactions to serine protease-like proteins of Staphylococcus aureus. Front Immunol. 2021;12:651060. doi: 10.3389/fimmu.2021.651060
   PubMed Web of Science ®Google Scholar
• Stentzel S, Teufelberger A, Nordengrün M, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492–500.e8. doi: 10.1016/j.jaci.2016.03.045
   PubMed Web of Science ®Google Scholar
• Teufelberger AR, Nordengrün M, Braun H, et al. The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus–derived serine protease–like protein D. J Allergy Clin Immunol. 2018;141(2):549–59.e7. doi: 10.1016/j.jaci.2017.05.004
   PubMed Web of Science ®Google Scholar
• Teufelberger AR, Van Nevel S, Hulpiau P, et al. Mouse strain-dependent difference toward the staphylococcus aureus allergen serine protease-like protein d reveals a novel regulator of IL-33. Front Immunol. 2020;11:582044. doi: 10.3389/fimmu.2020.582044
   PubMed Web of Science ®Google Scholar
• Tan NC, Foreman A, Jardeleza C, et al. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence. Laryngoscope. 2012;122:1655–1660. doi: 10.1002/lary.23317
   PubMed Web of Science ®Google Scholar
• Panchatcharam BS, Cooksley CM, Ramezanpour M, et al. Staphylococcus aureus biofilm exoproteins are cytotoxic to human nasal epithelial barrier in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10(7):871–883. doi: 10.1002/alr.22566
   PubMed Web of Science ®Google Scholar
• Frey AM, Chaput D, Shaw LN. Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus. Cell Rep. 2021;35(1):108930. doi: 10.1016/j.celrep.2021.108930
   PubMed Web of Science ®Google Scholar
• Murphy J, Ramezanpour M, Stach N, et al. Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro. Laryngoscope. 2018;128(1):E8–E15. doi: 10.1002/lary.26949
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhao Y, Hayes AJ, et al. Staphylococcus aureus small colony variants: Prevalence in chronic rhinosinusitis and induction by antibiotics. Allergy. 2018;73(12):2403–2405. doi: 10.1111/all.13580
   PubMed Web of Science ®Google Scholar
• Tan NC, Cooksley CM, Roscioli E, et al. Small-colony variants and phenotype switching of intracellular Staphylococcus aureus in chronic rhinosinusitis. Allergy. 2014;69(10):1364–1371. doi: 10.1111/all.12457
   PubMed Web of Science ®Google Scholar
• Lan F, Zhang N, Holtappels G, et al. Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines. Am J Respir Crit Care Med. 2018;198:452–463.
   PubMed Web of Science ®Google Scholar
• Sachse F, Becker K, Von Eiff C, et al. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy: Eur J Allergy Clin Immunol. 2010;65(11):1430–1437. doi: 10.1111/j.1398-9995.2010.02381.x
   Google Scholar
• Martens K, Seys SF, Alpizar YA, et al. Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity. Clin Exp Immunol. 2021;51(1):87–98. doi: 10.1111/cea.13760
   Google Scholar
• Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun. 2007;75(2):1040–1044. doi: 10.1128/IAI.01313-06
   PubMed Web of Science ®Google Scholar
• Ziesemer S, Eiffler I, Schonberg A, et al. Staphylococcus aureus alpha-toxin induces actin filament remodeling in human airway epithelial model cells. Am J Respir Cell Mol Biol. 2018;58:482–491. doi: 10.1165/rcmb.2016-0207OC
   PubMed Web of Science ®Google Scholar
• Hermann I, Rath S, Ziesemer S, et al. Staphylococcus aureus hemolysin a disrupts cell-matrix adhesions in human airway epithelial cells. Am J Respir Cell Mol Biol. 2015;52:14–24. doi: 10.1165/rcmb.2014-0082OC
   PubMed Web of Science ®Google Scholar
• Murphy J, Ramezanpour M, Drilling A, et al. In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus. Int Forum Allergy Rhinol. 2019;9(2):187–196. doi: 10.1002/alr.22232
   PubMed Web of Science ®Google Scholar
• Thienhaus ML, Wohlers J, Podschun R, et al. Antimicrobial peptides in nasal secretion and mucosa with respect to Staphylococcus aureus colonization in chronic rhinosinusitis with nasal polyps. Rhinology. 2011;49(5):554–561. doi: 10.4193/Rhino11.072
   PubMed Web of Science ®Google Scholar
• Homma T, Kato A, Sakashita M, et al. Potential involvement of the epidermal growth factor receptor ligand epiregulin and matrix metalloproteinase-1 in pathogenesis of chronic rhinosinusitis. Am J Respir Cell Mol Biol. 2017;57:334–345. doi: 10.1165/rcmb.2016-0325OC
   PubMed Web of Science ®Google Scholar
• Lan F, Zhong H, Zhang N, et al. IFN-λ1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps. J Allergy Clin Immunol. 2019;143(4):1416–25.e4. doi: 10.1016/j.jaci.2018.09.041
   PubMed Web of Science ®Google Scholar
• Krysko O, Holtappels G, Zhang N, et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy: Eur J Allergy Clin Immunol. 2011;66(3):396–403. doi: 10.1111/j.1398-9995.2010.02498.x
   Google Scholar
• Biggs TC, Hayes SM, Harries PG, et al. Immunological profiling of key inflammatory drivers of nasal polyp formation and growth in chronic rhinosinusitis. Rhinology. 2019;57(5):336–342. doi: 10.4193/Rhin19.167
   PubMed Web of Science ®Google Scholar
• Hayes SM, Biggs TC, Goldie SP, et al. Staphylococcus aureus internalization in mast cells in nasal polyps: characterization of interactions and potential mechanisms. J Allergy Clin Immunol. 2020;145(1):147–159. doi: 10.1016/j.jaci.2019.06.013
   PubMed Web of Science ®Google Scholar
• Feng T, Miao P, Liu B, et al. Sinus microbiota in patients with eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Front Cell Infect Microbiol. 2021;11:672355. doi: 10.3389/fcimb.2021.672355
   PubMed Web of Science ®Google Scholar
• Lee K, Zhang I, Kyman S, et al. Co-infection of malassezia sympodialis with bacterial pathobionts pseudomonas aeruginosa or staphylococcus aureus leads to distinct sinonasal inflammatory responses in a murine acute sinusitis model. Front Cell Infect Microbiol. 2020;10:472. doi: 10.3389/fcimb.2020.00472
   PubMedGoogle Scholar
• Wang X, Zhang N, Glorieux S, et al. Herpes simplex virus type 1 infection facilitates invasion of Staphylococcus aureus into the nasal mucosa and nasal polyp tissue. PLoS One. 2012;7(6):e39875. doi: 10.1371/journal.pone.0039875
   PubMed Web of Science ®Google Scholar
• Chalermwatanachai T, Vilchez-Vargas R, Holtappels G, et al. Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. Sci Rep. 2018;8(1):7926. doi: 10.1038/s41598-018-26327-2
   PubMed Web of Science ®Google Scholar
• Huang S, Hon K, Bennett C, et al. Corynebacterium accolens inhibits Staphylococcus aureus induced mucosal barrier disruption. Front Microbiol. 2022;13. doi: 10.3389/fmicb.2022.984741
   Web of Science ®Google Scholar
• De Boeck I, Wittouck S, Martens K, et al. The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms. Iscience. 2021;24:9.
   Web of Science ®Google Scholar
• Liu Q, Liu Q, Meng H, et al. Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe. 2020;27(1):68–78.e5. doi: 10.1016/j.chom.2019.11.003
   PubMed Web of Science ®Google Scholar
• Head K, Chong LY, Piromchai P, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011994. doi: 10.1002/14651858.CD011994.pub2
   PubMedGoogle Scholar
• Schalek P, Petrás P, Klement V, et al. Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains. Eur Arch Otorhinolaryngol. 2009;266(12):1909–1913. doi: 10.1007/s00405-009-1049-x
   PubMed Web of Science ®Google Scholar
• Maniakas A, Asmar MH, Renteria AE, et al. Azithromycin in high-risk, refractory chronic rhinosinusitis after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial. Int Forum Allergy Rhinol. 2021;11(4):747–754. doi: 10.1002/alr.22691
   PubMed Web of Science ®Google Scholar
• Renteria AE, Maniakas A, Mfuna LE, et al. Low-dose and long-term azithromycin significantly decreases Staphylococcus aureus in the microbiome of refractory CRS patients. Int Forum Allergy Rhinol. 2021;11(2):93–105. doi: 10.1002/alr.22653
   PubMed Web of Science ®Google Scholar
• Jervis-Bardy J, Boase S, Psaltis A, et al. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope. 2012;122(10):2148–2153. doi: 10.1002/lary.23486
   PubMed Web of Science ®Google Scholar
• Seiberling KA, Aruni W, Kim S, et al. The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus. Int Forum Allergy Rhinol. 2013;3:94–98. doi: 10.1002/alr.21076
   PubMed Web of Science ®Google Scholar
• Jervis-Bardy J, Wormald PJ. Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2012;2(2):111–115. doi: 10.1002/alr.20106
   PubMed Web of Science ®Google Scholar
• Videler WJ, van Drunen CM, Reitsma JB, et al. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology. 2008;46:92–98.
   PubMed Web of Science ®Google Scholar
• Feizi S, Cooksley CM, Nepal R, et al. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Pathology. 2022;54(4):453–459. doi: 10.1016/j.pathol.2021.08.014
   PubMed Web of Science ®Google Scholar
• Tian P, Ye W, Zhang X, et al. Ten-step asymmetric total syntheses of potent antibiotics anthracimycin and anthracimycin B. Chem Sci. 2022;13(43):12776–12781. doi: 10.1039/D2SC05049H
   PubMed Web of Science ®Google Scholar
• Bachert C, Holtappels G, Merabishvili M, et al. Staphylococcus aureus controls interleukin-5 release in upper airway inflammation. J Proteomics. 2018;180:53–60. doi: 10.1016/j.jprot.2017.12.003
   PubMed Web of Science ®Google Scholar
• Drilling AJ, Ooi ML, Miljkovic D, et al. Long-term safety of topical bacteriophage application to the frontal sinus region. Front Cell Infect Microbiol. 2017;7:49. doi: 10.3389/fcimb.2017.00049
   PubMed Web of Science ®Google Scholar
• Drilling A, Morales S, Boase S, et al. Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis. Int Forum Allergy Rhinol. 2014;4(3):176–186. doi: 10.1002/alr.21270
   PubMed Web of Science ®Google Scholar
• Rodriguez JM, Woodworth BA, Horne B, et al. Case report: successful use of phage therapy in refractory MRSA chronic rhinosinusitis. Int J Infect Dis. 2022;121:14–16. doi: 10.1016/j.ijid.2022.04.049
   PubMed Web of Science ®Google Scholar
• Ooi ML, Drilling AJ, Morales S, et al. Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to Staphylococcus aureus. JAMA Otolaryngology–Head & Neck Surg. 2019;145(8):723–729. doi: 10.1001/jamaoto.2019.1191
   PubMed Web of Science ®Google Scholar
• Doub JB, Johnson AJ, Nandi S, et al. Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: a case series. Clin Infect Dis. 2022;76(3):e1463–e1466. doi: 10.1093/cid/ciac694
   Google Scholar
• Wang F, Xiao Y, Lu Y, et al. Bacteriophage lytic enzyme P9ly as an alternative antibacterial agent against antibiotic-resistant shigella dysenteriae and Staphylococcus aureus. Front Microbiol. 2022;13:821989. doi: 10.3389/fmicb.2022.821989
   PubMed Web of Science ®Google Scholar
• Bispo M, Santos SB, Melo LDR, et al. Targeted antimicrobial photodynamic therapy of biofilm-embedded and intracellular staphylococci with a phage endolysin’s cell binding domain. Microbiol Spectr. 2022;10(1):e0146621. doi: 10.1128/spectrum.01466-21
   PubMedGoogle Scholar
• Gong C, Guan W, Liu X, et al. Biomimetic bacteriophage-like particles formed from probiotic extracts and no donors for eradicating multidrug-resistant Staphylococcus aureus. Adv Mater. 2022;34(45):e2206134. doi: 10.1002/adma.202206134
   PubMed Web of Science ®Google Scholar
• Liu S, Zhao Y, Hayes A, et al. Overcoming bacteriophage insensitivity in Staphylococcus aureus using clindamycin and azithromycin at subinhibitory concentrations. Allergy. 2021;76(11):3446–3458. doi: 10.1111/all.14883
   PubMed Web of Science ®Google Scholar
• Save J, Que YA, Entenza J, et al. Subtherapeutic doses of vancomycin synergize with bacteriophages for treatment of experimental methicillin-resistant Staphylococcus aureus infective endocarditis. Viruses. 2022;14(8):1792.
   PubMed Web of Science ®Google Scholar
• Save J, Que YA, Entenza JM, et al. Bacteriophages combined with subtherapeutic doses of flucloxacillin act synergistically against Staphylococcus aureus experimental infective endocarditis. J Am Heart Assoc. 2022;11(3):e023080. doi: 10.1161/JAHA.121.023080
   PubMed Web of Science ®Google Scholar
• Kebriaei R, Lev KL, Shah RM, et al. Eradication of biofilm-mediated methicillin-resistant staphylococcus aureus infections in vitro: bacteriophage-antibiotic combination. Microbiol Spectr. 2022;10(2):e0041122. doi: 10.1128/spectrum.00411-22
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. doi: 10.1016/j.jaci.2020.11.013
   PubMed Web of Science ®Google Scholar
• Beck LA, Bieber T, Weidinger S, et al. Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial. J Am Acad Dermatol. 2022;88(4):816–823. doi: 10.1016/j.jaad.2022.11.047
   PubMed Web of Science ®Google Scholar
• Olesen CM, Ingham AC, Thomsen SF, et al. Changes in skin and nasal microbiome and Staphylococcal species following treatment of atopic dermatitis with dupilumab. Microorganisms. 2021;9(7):1487. doi: 10.3390/microorganisms9071487
   PubMed Web of Science ®Google Scholar
• Cope EK, Goldberg AN, Pletcher SD, et al. Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences. Microbiome. 2017;5(1):53. doi: 10.1186/s40168-017-0266-6
   PubMedGoogle Scholar
• Ramakrishnan VR, Hauser LJ, Feazel LM, et al. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome. J Allergy Clin Immunol. 2015;136(2):334–42.e1. doi: 10.1016/j.jaci.2015.02.008
   PubMed Web of Science ®Google Scholar
• Hoggard M, Waldvogel-Thurlow S, Zoing M, et al. Inflammatory endotypes and microbial associations in chronic rhinosinusitis. Front Immunol. 2018;9:2065. doi: 10.3389/fimmu.2018.02065
   PubMed Web of Science ®Google Scholar
• Callewaert C, Nakatsuji T, Knight R, et al. IL-4Rα blockade by dupilumab decreases staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140(1):191–202.e7. doi: 10.1016/j.jid.2019.05.024
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim SE, Shin KO, et al. Dupilumab therapy improves stratum corneum hydration and skin dysbiosis in patients with atopic dermatitis. Allergy Asthma Immunol Res. 2021;13(5):762–775. doi: 10.4168/aair.2021.13.5.762
   PubMed Web of Science ®Google Scholar
• Geng B, Bachert C, Busse WW, et al. Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies. J Allergy Clin Immunol Pract. 2022;10(3):732–741. doi: 10.1016/j.jaip.2021.12.006
   PubMed Web of Science ®Google Scholar
• Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;2016(4):Cd011995. doi: 10.1002/14651858.CD011995.pub2
   Google Scholar
• Liu CM, Kohanski MA, Mendiola M, et al. Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. Int Forum Allergy Rhinol. 2015;5(3):185–190. doi: 10.1002/alr.21467
   PubMed Web of Science ®Google Scholar
• Seiberling KA, McHugh RK, Aruni W, et al. The impact of intraoperative saline irrigations on bacterial load within the maxillary sinus. Int Forum Allergy Rhinol. 2011;1(5):351–355. doi: 10.1002/alr.20075
   PubMed Web of Science ®Google Scholar
• Raza T, Elsherif HS, Zulianello L, et al. Nasal lavage with sodium hypochlorite solution in Staphylococcus aureus persistent rhinosinusitis. Rhinology. 2008;46:15–22.
   PubMed Web of Science ®Google Scholar
• Lee VS, Humphreys IM, Purcell PL, et al. Manuka honey sinus irrigation for the treatment of chronic rhinosinusitis: a randomized controlled trial. Int Forum Allergy Rhinol. 2017;7(4):365–372. doi: 10.1002/alr.21898
   PubMed Web of Science ®Google Scholar
• Ooi ML, Jothin A, Bennett C, et al. Manuka honey sinus irrigations in recalcitrant chronic rhinosinusitis: phase 1 randomized, single-blinded, placebo-controlled trial. Int Forum Allergy Rhinol. 2019;9(12):1470–1477. doi: 10.1002/alr.22423
   PubMed Web of Science ®Google Scholar
• Bennett C, Ramezanpour M, Cooksley C, et al. Kappa-carrageenan sinus rinses reduce inflammation and intracellular Staphylococcus aureus infection in airway epithelial cells. Int Forum Allergy Rhinol. 2019;9(8):918–925. doi: 10.1002/alr.22360
   PubMed Web of Science ®Google Scholar
• Singhal D, Jekle A, Debabov D, et al. Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis. Int Forum Allergy Rhinol. 2012;2(4):309–315. doi: 10.1002/alr.21038
   PubMed Web of Science ®Google Scholar
• Mukerji SS, Pynnonen MA, Kim HM, et al. Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial. Otolaryngol Head Neck Surg. 2009;140(2):202–208. doi: 10.1016/j.otohns.2008.11.020
   PubMed Web of Science ®Google Scholar
• Pivniouk V, Gimenes-Junior JA, Ezeh P, et al. Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis. J Allergy Clin Immunol. 2022;149(3):943–956. doi: 10.1016/j.jaci.2021.09.013
   PubMed Web of Science ®Google Scholar
• De Boeck I, van den Broek MFL, Allonsius CN, et al. Lactobacilli have a niche in the human nose. Cell Rep. 2020;31:107674. doi: 10.1016/j.celrep.2020.107674
   PubMed Web of Science ®Google Scholar
• Lambert PA, Gill AL, Gill SR, et al. Microbiomics of irrigation with xylitol or Lactococcus lactis in chronic rhinosinusitis. Laryngoscope Investig Otolaryngol. 2021;6:64–70. doi: 10.1002/lio2.524
   PubMed Web of Science ®Google Scholar
• Mårtensson A, Greiff L, Lamei SS, et al. Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers. Int Forum Allergy Rhinol. 2016;6(9):956–963. doi: 10.1002/alr.21762
   PubMed Web of Science ®Google Scholar
• Endam LM, Alromaih S, Gonzalez E, et al. Intranasal application of Lactococcus lactis W136 is safe in chronic rhinosinusitis patients with previous sinus surgery. Front Cell Infect Microbiol. 2020;10:440. doi: 10.3389/fcimb.2020.00440
   PubMed Web of Science ®Google Scholar
• Menberu MA, Cooksley C, Ramezanpour M, et al. In vitro and in vivo evaluation of probiotic properties of Corynebacterium accolens isolated from the human nasal cavity. Microbiol Res. 2021;255:126927. doi: 10.1016/j.micres.2021.126927
   PubMedGoogle Scholar
• Menberu MA, Liu S, Cooksley C, et al. Corynebacterium accolens has antimicrobial activity against Staphylococcus aureus and methicillin-resistant S. aureus pathogens isolated from the sinonasal niche of chronic rhinosinusitis patients. Pathogens. 2021;10(2):10. doi: 10.3390/pathogens10020207
   Web of Science ®Google Scholar
• Frost I, Sati H, Garcia-Vello P, et al. The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline. Lancet Microbe. 2022;4(2):e113–e125. doi: 10.1016/S2666-5247(22)00303-2
   PubMedGoogle Scholar
• Super M, Doherty EJ, Cartwright MJ, et al. Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock. Nat Biomed Eng. 2022;6:8–18. doi: 10.1038/s41551-021-00756-3
   PubMed Web of Science ®Google Scholar
• Yu YJ, Yan JH, Chen QW, et al. Polymeric nano-system for macrophage reprogramming and intracellular MRSA eradication. J Control Release. 2022;353:591–610. doi: 10.1016/j.jconrel.2022.12.014
   PubMed Web of Science ®Google Scholar
• Pan T, Chen H, Gao X, et al. Engineering efficient artificial nanozyme based on chitosan grafted Fe-doped-carbon dots for bacteria biofilm eradication. J Hazard Mater. 2022;435:128996. doi: 10.1016/j.jhazmat.2022.128996
   PubMed Web of Science ®Google Scholar
• Zheng J, Wang W, Gao X, et al. Cascade catalytically released nitric oxide-driven nanomotor with enhanced penetration for antibiofilm. Small. 2022;18(52):e2205252. doi: 10.1002/smll.202205252
   PubMed Web of Science ®Google Scholar
• He X, Dai L, Ye L, et al. A vehicle-free antimicrobial polymer hybrid gold nanoparticle as synergistically therapeutic platforms for Staphylococcus aureus infected wound healing. Adv Sci. 2022;9:e2105223. doi: 10.1002/advs.202105223
   Web of Science ®Google Scholar
• Szaleniec J, Gibała A, Stalińska J, et al. Biocidal Activity of tannic acid-prepared silver nanoparticles towards pathogens isolated from patients with exacerbations of chronic rhinosinusitis. Int J Mol Sci. 2022;23(23):23. doi: 10.3390/ijms232315411
   Web of Science ®Google Scholar
• Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114(4):981–983. doi: 10.1016/j.jaci.2004.07.013
   PubMed Web of Science ®Google Scholar
• Schleich F, Moermans C, Gerday S, et al. Asthmatics only sensitized to Staphylococcus aureus enterotoxins have more exacerbations, airflow limitation, and higher levels of sputum IL-5 and IgE. J Allergy Clin Immunol Pract. 2023. doi: 10.1016/j.jaip.2023.05.043
   PubMedGoogle Scholar
• Heymans F, Fischer A, Stow NW, et al. Screening for staphylococcal superantigen genes shows no correlation with the presence or the severity of chronic rhinosinusitis and nasal polyposis. PLoS One. 2010;5(3):e9525. doi: 10.1371/journal.pone.0009525
   PubMed Web of Science ®Google Scholar
• Wagner Mackenzie B, Baker J, Douglas RG, et al. Detection and quantification of Staphylococcus in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(12):1462–1469. doi: 10.1002/alr.22425
   PubMed Web of Science ®Google Scholar
• Damm M, Quante G, Jurk T, et al. Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2004;131(3):200–206. doi: 10.1016/j.otohns.2004.02.050
   PubMed Web of Science ®Google Scholar
• Wagner Mackenzie B, Zoing M, Clow F, et al. Characterising clinical Staphylococcus aureus isolates from the sinuses of patients with chronic rhinosinusitis. Sci Rep. 2021;11(1):21940. doi: 10.1038/s41598-021-01297-0
   PubMed Web of Science ®Google Scholar
• Altunbulakli C, Costa R, Lan F, et al. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018;142(2):665–8.e8. doi: 10.1016/j.jaci.2018.01.046
   PubMed Web of Science ®Google Scholar
• Valera FCP, Ruffin M, Adam D, et al. Staphylococcus aureus impairs sinonasal epithelial repair: effects in patients with chronic rhinosinusitis with nasal polyps and control subjects. J Allergy Clin Immunol. 2019;143(2):591–603.e3. doi: 10.1016/j.jaci.2018.05.035
   PubMed Web of Science ®Google Scholar